Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Accidents with radioactive pollution. Can we do something?].

J Norum1, E Wist

  • 1Kreftavdelingen, Regionsykehuset i Tromsø.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|April 10, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of acute myocardial infarction in the sub-arctic region of Norway. Do we offer an equal quality of care?

International journal of circumpolar health·2017
Same author

Prostate and breast cancer in four Nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975-2013.

International journal of cancer·2017
Same author

Delay in diagnosis and treatment of breast cancer in northern Norway.

Oncology reports·2011
Same author

Radiotherapy costs in glioblastoma.

Oncology reports·2011
Same author

Quality of life (QoL) measurement in economical analysis in cancer.

Oncology reports·2011
Same author

Quality of life in Dukes' B and C colorectal carcinoma.

Oncology reports·2011

Early administration of hematopoietic growth factors like G-CSF or GM-CSF shows promise for treating acute radiation syndrome following nuclear accidents. Bone marrow transplantation has limited value, while supportive care remains crucial.

Area of Science:

  • Radiation oncology
  • Hematology
  • Medical countermeasures

Context:

  • Nuclear accidents pose significant public health risks.
  • High-dose total body irradiation often leads to ineffective treatments.
  • Hematopoietic growth factors offer a potential therapeutic avenue.

Purpose:

  • To evaluate the efficacy of hematopoietic growth factors in treating radiation exposure.
  • To review animal studies and human clinical experience post-nuclear accidents.
  • To assess the role of bone marrow transplantation in radiation injury management.

Summary:

  • Granulocyte-colony stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) administered within three hours post-accident show therapeutic value.
  • Animal studies and human clinical data inform treatment strategies.

Related Experiment Videos

  • Supportive care including blood product transfusions and management of burns and GI symptoms is vital.

    • Impact:

    • Early G-CSF or GM-CSF intervention may improve outcomes for radiation-exposed individuals.
    • Findings guide clinical practice for nuclear accident medical response.
    • Highlights the limitations of bone marrow transplantation in certain radiation scenarios.